LATRECE ATHOURISTE: Open Payments
NPI 1154885929 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,249 in 67 payments from 10 companies in 2025. Trend: 2023 $510 · 2024 $1,080 · 2025 $1,249
Food & beverage: $1,249
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 17 | $472 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 19 | $317 |
| ABBVIE INC. | 17 | $214 |
| E.R. Squibb & Sons, L.L.C. | 5 | $104 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Alkermes, Inc. | 2 | $30 |
| Almatica Pharma LLC | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| Neurocrine BioSciences, Inc. | 1 | $14 |
Products named: Auvelity, CAPLYTA, VRAYLAR, COBENFY, REXULTI, ARISTADA, LOREEV XR, FANAPT.
Industry payments across FL — which companies pay providers there.
